Jodi Warman Chardon
Clinician-Scientist, Director of the Ottawa Neuromuscular Centre, The Ottawa Hospital; Associate Scientist, OHRI; Scientist, CHEORI
Associate Professor of Neurology, Co-Director of the Centre for Neuromuscular Disease, University of Ottawa
NMD4C Involvement: Pillar 2: Clinical Research, Theme 5: Open Science
Email JodiBiography
Dr. Jodi Warman Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease and Associate Professor of Neurology at University of Ottawa. She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She is also co-director (with Dr Robin Parks) of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers.
Dr. Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University. She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG).
Dr. Warman’s clinical research focuses on improved genomic and imaging studies for patients with inherited myopathies and neuromuscular disorders. She represents adult NMDs as a member of the NMD4C Steering Committee and will ensure that the next generation of NMD scientists and clinicians is engaged in all activities of the work plan. She participates in genomics education for the network, leading on engaging trainees and early-career researchers.
Recent Publications
Daniel, E, Smith, IC, Ly, V, Bourque, PR, Breiner, A, Lochmuller, H et al.. Direct and indirect costs of idiopathic inflammatory myopathies in adults: A systematic review. PLoS One. 2024.19 (7)e0307144 PMID:39058702
Warman-Chardon, J, Breiner, A, Bourque, PR. Inclusion body myositis. CMAJ. 2024.196 (14)E486 PMID:38621777
Esteller, D, Schiava, M, Verdú-Díaz, J, Villar-Quiles, RN, Dibowski, B, Venturelli, N et al.. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis. J Neurol. 2024.271 (4)2147-2148 PMID:38349561
Donkervoort, S, Mohassel, P, O'Leary, M, Bonner, DE, Hartley, T, Acquaye, N et al.. Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. Ann Clin Transl Neurol. 2024.11 (3)629-640 PMID:38311799
Warman-Chardon, J, Hartley, T, Marshall, AE, McBride, A, Couse, M, Macdonald, W et al.. Biallelic SOX8 Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction. Neurol Genet. 2023.9 (5)e200088 PMID:38235364
See more on PubMed